Human umbilical cord blood treatment in a mouse model of ALS: Optimization of cell dose

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Garbuzova Davis, Svitlana ^a   Sanberg, Cyndy Davis ^b   Kuzmin Nichols, Nicole ^b   Willing, Alison E ^a   Gemma, Carmelina ^a   Bickford, Paula C ^a   Miller, Christina ^a   Rossi, Robert ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MITOGENIC AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD CELL; BRAIN; CELL DENSITY; CELL THERAPY; CERVICAL SPINAL CORD; CONTROLLED STUDY; DISEASE COURSE; IMMUNE RESPONSE; LIFESPAN; LUMBAR SPINAL CORD; LYMPHOCYTOSIS; MALE; MICROGLIA; MONONUCLEAR CELL; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NEUTROPENIA; NONHUMAN; SPINAL CORD; SPLEEN CELL; UMBILICAL CORD BLOOD; ANIMAL; C57BL MOUSE; DISEASE MODEL; FETUS BLOOD; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ANIMALIA; MUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FETAL BLOOD; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL;

EID: 49249084301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002494     Document Type: Article

References (43)

1. Miller RG, Anderson FJ, Bradley WG, Brooks BR, Mitsumoto H, et al. (2000) The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology 54: 53-57.
2. Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. New Engl J Med 344: 1688-1700.
3. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62
4. Boillee S, Velde CV, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59.
5. Cao QL, Zhang YP, Howard RM, Walters WM, Tsoulfas P, et al. (2001) Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol 167: 48-58.
6. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, et al. (1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5: 1410-1412.
7. Bruijn LI (2002) Amyotrophic lateral sclerosis: from disease mechanisms to therapies. Biotechniques 32: 1112-1116.
8. Lindvall O, Kokaia Z, Martinez-Serrano A (2004) Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10: S42-50.
9. Hemendinger R, Wang J, Malik S, Persinski R, Copeland J, et al. (2005) Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Exp Neurol 196; 235-243.
10. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819.
11. Niebroj-Dobosz I, Jamrozik Z, Janis P, Hausmanowa-Petrusewicz I, Kwiecinski H (1999) Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 100: 238-243.
12. Alexianu ME (1995) The role of immune processes in amyotrophic lateral sclerosis pathogenesis. Rom J Neurol Psychiatry 33: 215-227.
13. Alexianu ME, Kozovska M, Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57: 1282-1289.
14. Appel SH, Smith RG, Engelhardt JI, Stefani E (1994) Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 121 Suppl: 11-19.
15. Kawamata T, Akiyama H, Yamada T, McGeer PL (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140: 691-707.
16. Broxmeyer HE (1996) Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells. Cancer Treat Res 84: 139-118.
17. Cardoso AA, Li ML, Batard P, Sansilvestri P, Hatzfeld A, et al. (1993) Human umbilical cord blood CD34+ cell purification with high yield of early progenitors. J Hematother 2: 275-279.
18. Mayani H, Lansdorp PM (1998) Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 16: 153-165.
19. Nayar B, Raju GM, Deka D (2002) Hematopoietic stem/progenitor cell harvesting from umbilical cord blood. Int J Gynaecol Obstet 79: 31-32.
20. Todaro AM, Pafumi G, Pernicone G, Munda S, Pilastro MR, et al. (2000) Haematopoietic progenitors from umbilical cord blood. Blood Purif 18: 144-147.
21. Bicknese AR, Goodwin HS, Quinn GO, Henderson VC, Chien SN, et al. (2002) Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant 11: 261-264.
22. Nakahata T, Ogawa M (1982) Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 70: 1324-1328.
23. Sanchez-Ramos JR, Song S, Kamath SG, Zigova T, Willing A, et al. (2001) Expression of neural markers in human umbilical cord blood. Exp Neurol 171: 109-115.
24. Chen N, Hudson JE, Walczak P, Misiuta I, Garbuzova-Davis S, et al. (2005) Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells 23: 1560-1570.
25. Rainsford EDR (2002) Interleukin 10, produced in abudance by human newborn T cell, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 116: 702-709.
26. Garbuzova-Davis S, Willing AE, Saporta S, Bickford PC, Gemma C, et al. (2006) Chapter 14 Novel cell therapy approaches for brain repair. Prog Brain Res 157: 207-222.
27. Sanberg PR, Willing AE, Garbuzova-Davis S, Saporta S, Liu G, et al. (2005) Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci 1049: 67-83.
28. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, et al. (2005) Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14: 595-604.
29. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, et al. (2006) Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 199: 191-200.
30. Sanberg PR, Willing AE, Davis Sanberg C, Kazi Z, Borlongan CV (2004) Different functional recovery and neurostructural repair of the stroke brain produced by volume-reduced and mononuclear fractioned human umbilical cord blood. Program No6174 Abstract Viewer/Itinerary Planner Society for Neuroscience, Washington, DC.
31. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, et al. (2003) Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Journal of Hematotherapy & Stem Cell Research 12: 255-270.
32. Ende N, Weinstein F, Chen R, Ende M (2000) Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 67: 53-59.
33. Chen R, Ende N (2000) The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 31: 21-30.
34. Hall Ed, Oostveen JA, Gurney ME (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23: 249-256.
35. McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26: 459-470.
36. Elliott JL (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95: 172-178.
37. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, et al. (2001) Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49: 176-185.
38. Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, et al. (2002) Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 82: 365-371.
39. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, et al. (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80: 158-167.
40. Kuzmenok OI, Sanberg PR, Desjarlais TG, Bennett SP, Garbuzova-Davis SN (2006) Lymphopenia and spontaneous autorosette formation in SOD1 mouse model of ALS. J Neuroimmunol 172: 132-136.
41. Garbuzova-Davis S, Willing AE, Milliken M, Saporta S, Sowerby B, et al. (2001) Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. Amyotroph Lateral Scler Other Motor Neuron Disord 2: 175-180.
42. Garbuzova-Davis S, Willing AE, Milliken M, Saporta S, Zigova T, et al. (2002) Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol 174: 169-180.
43. Gemma C, Mesches MH, Sepesi B, Choo K, Holmes DB, et al. (2002) Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines. J Neurosci 22: 6114-6120.